Apixaban: An oral anticoagulant having unique mechanism of action with better safety and efficacy profile
Anticoagulants are routinely used in stroke, embolism, infarct, etc. Blood clotting profile in such patients needs to be monitored frequently. Anticoagulants which can be administered orally such as warfarin and dicoumarol are preferred in such patients. Injectable anticoagulants such as heparin are...
Main Author: | Z A Fazeel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | MAMC Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.mamcjms.in/article.asp?issn=2394-7438;year=2016;volume=2;issue=2;spage=63;epage=68;aulast=Fazeel |
Similar Items
-
ORAL ANTICOAGULANTS IN THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS: FOCUS ON APIXABAN
by: M. Yu. Gilyarov, et al.
Published: (2017-12-01) -
Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism
by: Isabel Elías, et al.
Published: (2016-05-01) -
Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice
by: Stephan V. Hendriks, et al.
Published: (2020-04-01) -
Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry
by: Jan Beyer-Westendorf, et al.
Published: (2021-04-01) -
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
by: Alexander Cohen, et al.
Published: (2021-01-01)